BackAmylyx Pharmaceuticals Overview

Amylyx Pharmaceuticals Other Assets

Latest other assets for AMLX: $0.

Get informed when a big investor buys or sells

+ Follow
Other Assets
$0.00

Peer average

Loading

Amylyx Pharmaceuticals Other Assets History

Loading

Amylyx Pharmaceuticals vs. peers: Other Assets Comparison

Loading

Amylyx Pharmaceuticals Other Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Amylyx Pharmaceuticals (AMLX) FAQ

Amylyx Pharmaceuticals posts a other assets of $0 as of June 2026. In the prior-year period, the figure was $0. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Amylyx Pharmaceuticals's other assets was $0. The latest reading is $0 (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Other Assets is one piece of Amylyx Pharmaceuticals's financial statement story. At $0, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for AMLX's other assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Amylyx Pharmaceuticals's other metric pages and overview cover the third.